Parvathaneni, V.; Elbatanony, R.S.; Goyal, M.; Chavan, T.; Vega, N.; Kolluru, S.; Muth, A.; Gupta, V.; Kunda, N.K.
Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes. Int. J. Mol. Sci. 2021, 22, 4783.
https://doi.org/10.3390/ijms22094783
AMA Style
Parvathaneni V, Elbatanony RS, Goyal M, Chavan T, Vega N, Kolluru S, Muth A, Gupta V, Kunda NK.
Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes. International Journal of Molecular Sciences. 2021; 22(9):4783.
https://doi.org/10.3390/ijms22094783
Chicago/Turabian Style
Parvathaneni, Vineela, Rasha S. Elbatanony, Mimansa Goyal, Tejashri Chavan, Nathan Vega, Srikanth Kolluru, Aaron Muth, Vivek Gupta, and Nitesh K. Kunda.
2021. "Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes" International Journal of Molecular Sciences 22, no. 9: 4783.
https://doi.org/10.3390/ijms22094783
APA Style
Parvathaneni, V., Elbatanony, R. S., Goyal, M., Chavan, T., Vega, N., Kolluru, S., Muth, A., Gupta, V., & Kunda, N. K.
(2021). Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes. International Journal of Molecular Sciences, 22(9), 4783.
https://doi.org/10.3390/ijms22094783